294 related articles for article (PubMed ID: 21885490)
1. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.
Moldofsky H; Harris HW; Archambault WT; Kwong T; Lederman S
J Rheumatol; 2011 Dec; 38(12):2653-63. PubMed ID: 21885490
[TBL] [Abstract][Full Text] [Related]
2. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia.
Reynolds WJ; Moldofsky H; Saskin P; Lue FA
J Rheumatol; 1991 Mar; 18(3):452-4. PubMed ID: 1856814
[TBL] [Abstract][Full Text] [Related]
3. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study.
Moldofsky H; Lue FA; Mously C; Roth-Schechter B; Reynolds WJ
J Rheumatol; 1996 Mar; 23(3):529-33. PubMed ID: 8832997
[TBL] [Abstract][Full Text] [Related]
4. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
[TBL] [Abstract][Full Text] [Related]
6. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
Moldofsky H; Inhaber NH; Guinta DR; Alvarez-Horine SB
J Rheumatol; 2010 Oct; 37(10):2156-66. PubMed ID: 20682669
[TBL] [Abstract][Full Text] [Related]
7. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
Scharf MB; Baumann M; Berkowitz DV
J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
[TBL] [Abstract][Full Text] [Related]
8. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis.
Tofferi JK; Jackson JL; O'Malley PG
Arthritis Rheum; 2004 Feb; 51(1):9-13. PubMed ID: 14872449
[TBL] [Abstract][Full Text] [Related]
9. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
11. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
14. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.
Quimby LG; Gratwick GM; Whitney CD; Block SR
J Rheumatol Suppl; 1989 Nov; 19():140-3. PubMed ID: 2481741
[TBL] [Abstract][Full Text] [Related]
16. Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?
Rizzi M; Sarzi-Puttini P; Atzeni F; Capsoni F; Andreoli A; Pecis M; Colombo S; Carrabba M; Sergi M
J Rheumatol; 2004 Jun; 31(6):1193-9. PubMed ID: 15170935
[TBL] [Abstract][Full Text] [Related]
17. A randomized placebo-controlled study of noninvasive cortical electrostimulation in the treatment of fibromyalgia patients.
Hargrove JB; Bennett RM; Simons DG; Smith SJ; Nagpal S; Deering DE
Pain Med; 2012 Jan; 13(1):115-24. PubMed ID: 22233397
[TBL] [Abstract][Full Text] [Related]
18. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial.
Potvin S; Morin M; Cloutier C; Gendron A; Bissonnette A; Marchand S
J Clin Psychopharmacol; 2012 Oct; 32(5):684-7. PubMed ID: 22926604
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Distler O; Eich W; Dokoupilova E; Dvorak Z; Fleck M; Gaubitz M; Hechler M; Jansen JP; Krause A; Bendszus M; Pache L; Reiter R; Müller-Ladner U
Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
[TBL] [Abstract][Full Text] [Related]
20. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
Younger J; Noor N; McCue R; Mackey S
Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
